Purdue Drug Discovery Training Program
Purdue Drug Discovery Training Program
批准号:
10620817
负责人:
Emily Carla Dykhuizen
金额:
$19.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2024-06-30
中文摘要
摘要
英文摘要
Abstract
The objective of the Purdue Drug Discovery Training Program (PDD-TP) is to provide
predoctoral students with a comprehensive and balanced perspective of drug discovery and
development, and to develop a multi-disciplinary approach toward the design of novel molecular
entities with promising medicinal activity, with subsequent optimization and preclinical
evaluation. Trainees will take an integrated curriculum that expands their breadth of knowledge
and experimental approach toward the discovery of novel targets for drug development, and will
participate in a research embedding project outside their primary laboratory for further
experience and training. Trainees will also participate in program-specific activities intended to
enhance communication, critical thinking, leadership, management, mentorship, networking,
and entrepreneurism. Activities include a journal club, formal presentations of cross-disciplinary
research, organization of seminars in drug discovery, unique opportunities to engage experts in
the evaluation of drug pipeline candidates, and participation in a mock drug panel review. Every
effort will be made to maximize the diversity of training program applicants, and to recruit and
retain trainees of diverse backgrounds. PDD-TP trainees will graduate with a comprehensive
skill set and exposure to drug discovery and pipeline development, and with experiences that
will continue to serve them long after they enter the biomedical workforce.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3390/molecules26051227
发表时间:
2021-02-25
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
作者:
[Krabill AD, Chen H, Hussain S, Hewitt CS, Imhoff RD, Muli CS, Das C, Galardy PJ, Wendt MK, Flaherty DP]
通讯作者:
Flaherty DP
BAF complex inhibitors in neuronal development and functions
-
批准号:10528055
-
项目类别:
-
资助金额:$20.41万
-
财政年份:2022
-
负责人:Emily Carla Dykhuizen
-
依托单位:
BAF complex inhibitors in neuronal development and functions
-
批准号:10630241
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2022
-
负责人:Emily Carla Dykhuizen
-
依托单位:
Purdue Drug Discovery Training Program
-
批准号:10428481
-
项目类别:
-
资助金额:$20.81万
-
财政年份:2019
-
负责人:Emily Carla Dykhuizen
-
依托单位:
The tumor suppressive role of PBRM1, the bromodomain-containing subunit of the PBAF chromatin remodeling complex
-
批准号:9908057
-
项目类别:
-
资助金额:$34.92万
-
财政年份:2017
-
负责人:Emily Carla Dykhuizen
-
依托单位:
The tumor suppressive role of PBRM1, the bromodomain-containing subunit of the PBAF chromatin remodeling complex
-
批准号:9311552
-
项目类别:
-
资助金额:$34.94万
-
财政年份:2017
-
负责人:Emily Carla Dykhuizen
-
依托单位:
海外基金